We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

117 hedge funds and large institutions have $1.85B invested in Revolution Medicines in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $2.28M | Put options by funds: $1.27M

38% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 29

27% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 15

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

3% more funds holding

Funds holding: 114 → 117 (+3)

1.25% more ownership

Funds ownership: 98.26% → 99.51% (+1.3%)

7% less capital invested

Capital invested by funds: $1.99B → $1.85B (-$144M)

Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
1.8%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.14%
New
19
Increased
40
Reduced
29
Closed
15
Calls
$2.28M
Puts
$1.27M
Net Calls
+$1.01M
Net Calls Change
+$1.03M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$58.1M
2
BlackRock
BlackRock
New York
+$10.4M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.62M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.31M
5
Citigroup
Citigroup
New York
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$47.8M
2
CAM
Cormorant Asset Management
Massachusetts
-$20.1M
3
BI
BVF Inc
California
-$19M
4
DM
Deerfield Management
New York
-$19M
5
CC
Casdin Capital
New York
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
76
Erste Asset Management
Austria
$448K – – –
Blackstone Inc
77
Blackstone Inc
New York
$433K – – –
Handelsbanken Fonder
78
Handelsbanken Fonder
Sweden
$423K +$132K +4,700 +39%
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
$417K – – –
E
80
Ergoteles
New York
$410K +$459K +16,295 New
SFI
81
Susquehanna Fundamental Investments
Pennsylvania
$393K +$440K +15,601 New
Allspring Global Investments
82
Allspring Global Investments
North Carolina
$343K +$385K +13,666 New
N
83
Natixis
France
$332K +$372K +13,200 New
ASRS
84
Arizona State Retirement System
Arizona
$324K -$3.66K -130 -1%
Ensign Peak Advisors
85
Ensign Peak Advisors
Utah
$281K +$314K +11,150 New
FQ
86
First Quadrant
California
$269K – – –
ECM
87
ExodusPoint Capital Management
New York
$257K +$288K +10,226 New
FT
88
Fiduciary Trust
Massachusetts
$249K – – –
Janus Henderson Group
89
Janus Henderson Group
United Kingdom
$243K +$272K +9,666 New
Teacher Retirement System of Texas
90
Teacher Retirement System of Texas
Texas
$236K +$51.7K +1,835 +24%
DTL
91
Dynamic Technology Lab
Singapore
$225K -$227K -8,046 -47%
Principal Financial Group
92
Principal Financial Group
Iowa
$222K -$156K -5,534 -39%
AB
93
Amalgamated Bank
New York
$204K -$2.79K -99 -1%
MAM
94
Martingale Asset Management
Massachusetts
$202K – – –
TRCT
95
Tower Research Capital (TRC)
New York
$188K +$39.9K +1,417 +23%
VEA
96
Virtus ETF Advisers
New York
$170K +$16.8K +596 +10%
Zurich Cantonal Bank
97
Zurich Cantonal Bank
Switzerland
$170K +$49.2K +1,744 +35%
SG Americas Securities
98
SG Americas Securities
New York
$118K -$1.17M -41,514 -90%
AIP
99
Ameritas Investment Partners
Nebraska
$117K – – –
Royal Bank of Canada
100
Royal Bank of Canada
Ontario, Canada
$84K +$44.1K +1,565 +89%
2 3
4
5 6

RVMD Hedge Fund Activity: Q4 2021 in Review

117 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q4 2021, worth a combined $1.85B — down 7.2% from $1.99B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RVMD positions and 15 closed out — a net gain of 4 holders — while 40 added to existing stakes and 29 trimmed.

The largest buyer was Woodline Partners, adding an estimated $58.1M. The largest seller was Fidelity Investments, cutting an estimated $47.8M.

  • 117 institutional investors held Revolution Medicines (RVMD) as of Q4 2021, up from 114 in Q3 2021.
  • Funds reported $1.85B of Revolution Medicines stock for Q4 2021, down 7.2% quarter-over-quarter.
  • 19 funds opened new Revolution Medicines positions in Q4 2021 and 15 closed out, a net change of +4 holders.
  • The largest Revolution Medicines buyer in Q4 2021 was Woodline Partners, an estimated $58.1M added.
  • The largest Revolution Medicines seller in Q4 2021 was Fidelity Investments, an estimated $47.8M sold.

Based on aggregated 13F filings for Q4 2021.